HealthyDirect · GrowthFit for a long SIP
JM Large Cap Fund
JM Financial Mutual FundEquity Schemes - Large Cap Fund13.8 years
The scheme seeks long term capital growth and appreciation through investment primarily in equities.
- NAV
- 171.669
- 30 Oct 2026
- 1Y
- -5.7%
- Trailing CAGR
- AUM
- ₹355.56 Cr
- 30 Sept 2026
- Volatility
- Medium
- 13.5% annualized
Buying brief
Should you add this fund?
Evidence on this desk, framed as a purchase checklist - not SEBI-registered advice.
As of 30 Oct 2026
Stance
Fit for a long SIP
Evidence supports keeping this on a shortlist for a multi-year equity SIP.
In three lines
Fits if · No material deterioration, cost shock, or persistent category underperformance in the current evidence set.
Buy checklist
History depth
Pass
13.8 years of path to read.
Engine status
Pass
Evidence supports keeping this on a shortlist for a multi-year equity SIP.
Expense ratio
Pass
1.19% TER (Direct). Lower cost compounds on long SIPs.
Drawdown vs peers
Pass
Peak-to-trough -19.8%. Ask whether you can hold through a similar fall.
Vs category
Watch
42% of rolling 3Y windows beat the category median, same plan and option.
Manager tenure
Watch
Deepak Gupta · 1.8 years on the scheme.
Exit load
n/a
No exit-load summary on file.
Tax / wrapper
Pass
Direct Growth, no ELSS lock flagged. Equity LTCG rules still apply after one year - not tax advice.
Portfolio concentration
Pass
Top 10 holdings ≈ 32.8% of the portfolio.
Evidence supports a shortlist - confirm with peers before you buy elsewhere.
Before you buy or SIP
Behaviour and wrappers - the usual India MF failure modes - not a buy instruction.
Drawdown rehearsal
This scheme’s worst fall on file is about 20%. Before you SIP, ask whether you would keep contributing through a similar drop - pausing on fear is the usual India MF failure mode.
SIP discipline
If you start a SIP here, diary a 90-day check and an annual review - don’t react to every NAV print.
NAV
Path not in current snapshots
n/a
Returns
Trailing CAGR and simulated monthly SIP XIRR from daily NAV. Category comparison uses the median of comparable share classes in the peer set.
Trailing CAGR
Point-to-point, calendar-day annualized
- 1Y-5.7%
- 3Y+10.5%
- 5Y+9.5%
- 10Y+11.4%
- SI+11.9%
SIP XIRR
Equal monthly instalments to latest NAV
- 1Y-3.7%
- 3Y+1.1%
- 5Y+8.2%
- 10Y+11.5%
- Since inception
- +11.9%
- Calendar-day CAGR
- Excess 1Y
- +0.9%
- Category median, same plan and option
- 3Y win rate
- +42%
- Windows beating the median
- 3Y percentile
- 50
- Vs comparable share classes
- SIP 3Y XIRR
- +1.1%
- Simulated monthly SIP
- Worst rolling 3Y
- +0.7%
- 2658 daily-ending windows
- Median rolling 3Y
- +14.1%
- Calendar-day CAGR
- Positive rolling 5Y
- +100%
- 2162 daily-ending windows
Drawdown
Peak to trough from a running NAV high, with the path and recovery episodes.
- Max drawdown
- -19.8%
- Worst peak-to-trough
- Current
- -9.9%
- Below last peak
- Current spell
- 763 days
- Days below latest peak
- Time below peak
- +89%
- NAV observations
Drawdown
Path not in current snapshots
n/a
- Average recovery
- 13 days
- 149 recovered episodes
- Longest recovery
- 194 days
- Trough to prior peak
27 Sept 2024 – open
Trough 28 Feb 2025 · not recovered
-19.8%
2 Mar 2015 – 6 Sept 2016
Trough 25 Feb 2016 · recovered in 194 days
-19.5%
17 Jan 2022 – 14 Nov 2022
Trough 20 Jun 2022 · recovered in 147 days
-17.8%
17 May 2013 – 9 Dec 2013
Trough 28 Aug 2013 · recovered in 103 days
-17.3%
Dimensions
0–100 reads of named metrics. The mean is unweighted and only uses dimensions with data.
Returns
50
Vs category
56
Consistency
44
Risk-adjusted
49
Drawdown
51
Mean
50
Decision
Quantitative engine reasons behind the buying stance. An explanation can only restate what is already here.
Healthy
Buying stance
Fit for a long SIP
Evidence supports keeping this on a shortlist for a multi-year equity SIP.
Why this status
- No material deterioration, cost shock, or persistent category underperformance in the current evidence set.
Supporting reads
No supporting reads in the current evidence set.
Portfolio
30 Sept 2026 · 51 holdings · top 10 are 32.8%.
- Top 5
- 18.5%
- Top 10
- 32.8%
- Largest holding
- 4.6%
- Effective holdings
- 42.7
State Bank of India
Financial
4.6%
Bharti Airtel Ltd
Technology
3.9%
ICICI Bank Ltd
Financial
3.6%
Reliance Industries Ltd
Energy & Utilities
3.4%
Kotak Mahindra Bank Ltd
Financial
3.1%
What changed
DECISION
Status moved from HEALTHY to MONITOR.
27 Oct 2026
DECISION
Status moved from HEALTHY to MONITOR.
15 Sept 2026
Worth investigating
Same-category peers with enough history to inspect beside this fund - including tradeoffs.
WhiteOak Capital Large Cap Fund
WhiteOak Capital Mutual Fund
- 1Y
- -5.4%
- 3Y
- +13.2%
- Vol
- 12.6%
- Max DD
- -15.2%
- Sharpe
- 0.47
- 3Y win
- +100%
- Lower volatility
- Shallower drawdown
- Higher win rate vs category
- Lower TER
- Higher trailing returns
Invesco India Large Cap Fund
Invesco Mutual Fund
- 1Y
- -2.4%
- 3Y
- +14.0%
- Vol
- 15.6%
- Max DD
- -36.9%
- Sharpe
- 0.59
- 3Y win
- +73%
- Higher win rate vs category
- Lower TER
- Higher trailing returns
Caveat: Higher volatility · Deeper drawdown
Axis Large Cap Fund
Axis Mutual Fund
- 1Y
- -5.7%
- 3Y
- +9.3%
- Vol
- 14.6%
- Max DD
- -30.1%
- Sharpe
- 0.53
- 3Y win
- +44%
- Higher win rate vs category
- Lower TER
Caveat: Higher volatility · Deeper drawdown · Lower trailing returns
Canara Robeco Large Cap Fund
Canara Robeco Mutual Fund
- 1Y
- -7.9%
- 3Y
- +10.5%
- Vol
- 15.2%
- Max DD
- -32.6%
- Sharpe
- 0.54
- 3Y win
- +60%
- Higher win rate vs category
- Lower TER
Caveat: Higher volatility · Deeper drawdown · Lower trailing returns
Mahindra Manulife Large Cap Fund
Mahindra Manulife Mutual Fund
- 1Y
- -8.8%
- 3Y
- +9.2%
- Vol
- 16.4%
- Max DD
- -35.3%
- Sharpe
- 0.44
- 3Y win
- +70%
- Higher win rate vs category
- Lower TER
Caveat: Higher volatility · Deeper drawdown · Lower trailing returns